Cybeats - CYBCF STOCK NEWS

Welcome to our dedicated page for Cybeats news (Ticker: CYBCF), a resource for investors and traders seeking the latest updates and insights on Cybeats stock.

About Cybeats Technologies Corp. (CYBCF)

Cybeats Technologies Corp. is a global leader in cybersecurity, specializing in Software Bill of Materials (SBOM) management and software supply chain intelligence. Headquartered in Toronto, Ontario, Cybeats provides innovative solutions that help organizations manage risk, meet regulatory compliance, and secure their software ecosystems from procurement to development and operation. By offering comprehensive visibility and transparency into software supply chains, Cybeats empowers its clients to improve operational efficiency, enhance security, and drive revenue growth.

Core Offerings

At the heart of Cybeats' product suite is SBOM Studio, an industry-leading platform designed to streamline software vulnerability management, ensure regulatory compliance, and enhance supply chain transparency. SBOM Studio serves a diverse range of industries, including healthcare, industrial automation, and government sectors, enabling organizations to:

Identify and mitigate software supply chain risks in real-time.
Track and manage software vulnerabilities with automated risk analysis.
Ensure compliance with evolving regulations such as the U.S. Executive Order 14028 and the EU Cyber Resilience Act.
Facilitate secure SBOM sharing to foster trust and transparency with stakeholders.

Complementing SBOM Studio is SBOM Consumer, a solution tailored for organizations that procure and deploy software from multiple vendors. This platform simplifies SBOM ingestion, validation, and continuous monitoring, making it an essential tool for industries reliant on third-party software, such as healthcare and critical infrastructure.

Industry Leadership and Market Relevance

Cybeats has established itself as a trusted partner for some of the world's largest organizations, including Fortune 500 companies and government agencies like the U.S. Department of Defense. Its solutions align with global regulatory frameworks, providing clients with the tools needed to navigate complex compliance landscapes. In the healthcare sector, for instance, Cybeats supports medical device manufacturers (MDMs) in meeting FDA requirements for SBOMs, thereby enhancing patient safety and regulatory adherence.

The company's innovative approach extends to emerging technologies, with capabilities like AI Bill of Materials (AIBOM) management and AI Threat Intelligence Collection (AITIC). These advancements address the growing cybersecurity risks associated with artificial intelligence and software supply chains, further reinforcing Cybeats' market leadership.

Competitive Advantages

Cybeats differentiates itself through:

Comprehensive Solutions: Offering end-to-end SBOM management for both software producers and consumers.
Regulatory Alignment: Ensuring compliance with stringent regulations across North America and Europe.
Proven ROI: Demonstrating measurable cost savings and efficiency gains for clients, such as reducing vulnerability management efforts by up to 75%.
High Conversion Rates: Achieving a 90% conversion rate from product trials to long-term commercial licenses.
Strategic Partnerships: Collaborating with industry leaders like Rockwell Automation and the U.S. Department of Defense.

Market Outlook

As global cybersecurity threats continue to rise, the demand for SBOM solutions is accelerating. Cybeats is strategically positioned to capitalize on this trend, offering scalable solutions that address both current and future market needs. With a growing customer base, recurring revenue model, and focus on innovation, Cybeats is poised to remain a key player in the cybersecurity landscape.

Conclusion

Cybeats Technologies Corp. exemplifies innovation and leadership in the cybersecurity industry. Its cutting-edge solutions, regulatory expertise, and commitment to transparency make it an indispensable partner for organizations aiming to secure their software supply chains. Cybeats. Software Made Certain.

04/18/2024 09:22 PM

News

Cybeats Announces Filing of MCTO Application

Rhea-AI Summary

Cybeats Technologies Corp. announces a delay in filing its audited annual financial statements for the year ended December 31, 2023, due to the current auditor's inability to continue public company audits. The company has applied for a management cease trade order to address the late filing and anticipates completing the filings by June 30, 2024. Cybeats will provide bi-weekly default status reports and confirms no insolvency proceedings or undisclosed material information.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-6.89%

Tags

04/17/2024 09:20 AM

News

Cybeats Positioned to Benefit from New EU Regulation; €15M Fines Under Cyber Resilience Act Drive Urgency for SBOM Compliance

Rhea-AI Summary

Cybeats Technologies Corp. is positioned to benefit from the new EU Cyber Resilience Act, which enforces SBOM compliance with fines of up to €15 million or 2.5% of gross sales. The company's SBOM Studio offers a leading interface for managing software assets, aligning with increasing regulatory requirements. CEO Justin Leger emphasizes the importance of proactive cybersecurity measures. The Act covers all products with software connections, including IoT devices. The FDA also mandates SBOM for medical device cybersecurity, highlighting the importance of solutions like SBOM Studio.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-4.76%

Tags

04/15/2024 08:52 AM

News

Cybeats Signs Cybersecurity Deal with Top 3 European Telecom Leader

Rhea-AI Summary

Cybeats Technologies Corp. signs a cybersecurity deal with a top 3 European telecom leader, marking a significant milestone in the company's commercial journey. The SaaS agreement for SBOM Studio1 product aims to enhance cybersecurity practices in the telecom sector, leveraging Cybeats' industry-leading software. With a focus on regulatory compliance and security risks, Cybeats expects substantial commercial traction in this new market vertical.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

56.18%

Tags

04/03/2024 05:15 PM

News

Cybeats Announces Extension of Warrant Expiry

Rhea-AI Summary

Cybeats Technologies Corp. extends the expiry date of 32,591,800 common share purchase warrants, benefiting shareholders with extended exercise periods at unchanged prices.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

1.18%

Tags

02/07/2024 08:30 AM

News

Cybeats Signs Three Year, Seven Figure Contract with Global Top 5 Medical Device Manufacturer

Rhea-AI Summary

Cybeats Technologies Corp. has signed a renewed and expanded license agreement for SBOM Studio with a Top 5 global Medical Device Manufacturer, solidifying its position in the medical device industry. The contract term is now for three years and for over seven figures in total contract value. The company continues to achieve commercial progress evidenced by client retention and organic contract growth, illustrating increased product usage and demand. The FDA's role in regulating medical device cybersecurity and the significance of SBOM management solutions like SBOM Studio have been emphasized, highlighting the pivotal role of SBOM Studio in fortifying software supply chains, especially for globally-operating companies.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

0.69%

Tags

01/25/2024 06:07 PM

News

Cybeats Announces Closing of Private Placement

Rhea-AI Summary

Cybeats Technologies Corp. closed a non-brokered private placement, raising $2,025,000 through the issuance of debenture units. The company intends to use the net proceeds for working capital and general corporate purposes. Each debenture unit consists of unsecured convertible debentures and common share purchase warrants. The debentures mature in 24 months and accrue interest at 12% per annum. The principal amount is convertible into common shares at a conversion price of $0.30 per share. The forced conversion clause is triggered if the shares trade at or above $0.60 for 20 consecutive days. The securities issued are subject to a hold period of four months plus a day from the date of closing. The offering was a related party transaction, with an insider of the company subscribing for 210 debenture units.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-2.88%

Tags

01/22/2024 05:00 PM

News

Cybeats Announces Increase to Private Placement

Rhea-AI Summary

Cybeats Technologies Corp. has increased its non-brokered private placement to up to 2,025 debenture units for gross proceeds of up to $2,025,000. The company intends to use the net proceeds for working capital and general corporate purposes. Each debenture unit consists of unsecured convertible debentures and common share purchase warrants. The debentures accrue interest at 12% per annum and are convertible into common shares at a conversion price of $0.30 per share. The offering is subject to certain conditions including regulatory approvals.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-9.02%

Tags

01/09/2024 11:49 AM

News

Cybeats' CEO Provides Letter to Shareholders

Rhea-AI Summary

Cybeats Technologies Corp. (CYBT) provides a year-end letter to shareholders, showcasing a 250% annual recurring revenue growth and total contract values exceeding $4M in their first full year of commercial operations. The company's cybersecurity software, SBOM Studio, has 100% customer retention and has expanded contracts with 30% of existing customers. The 2024 growth strategy includes contract expansions, acquiring new enterprise clients, and entering new market segments.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-0.87%

Tags

12/20/2023 07:00 PM

News

Cybeats Announces Private Placement of Convertible Debenture Units

Rhea-AI Summary

Cybeats Technologies Corp. (CSE: CYBT) (OTCQB: CYBCF) announces a non-brokered private placement of up to 1,500 debenture units for gross proceeds of up to $1,500,000. The net proceeds will be used for working capital and general corporate purposes. Each debenture unit consists of $1,000 in principal amount of unsecured convertible debentures and 3,333 common share purchase warrants. The debentures accrue interest at 12% per annum and mature in 24 months, with the option to convert into common shares at a conversion price of $0.30 per share. The company may force conversion if the shares trade at or above $0.60 for 20 consecutive trading days.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-0.92%

Tags

11/27/2023 08:49 AM

News

Cybeats Partners with Health-ISAC, a Global Healthcare Cyber & Physical Security Organization, to Deliver Joint Commercial Solution, ';Health-ISAC SBOM Studio'

Rhea-AI Summary

Cybeats Technologies Corp. (CYBT) partners with Health Information Sharing and Analysis Center (Health-ISAC) to offer SBOM management solution for healthcare industry, creating significant revenue opportunity. SBOM Studio is already commercially validated and used by top global Medical Device Manufacturers.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

32.67%

Tags

FAQ

What is the current stock price of Cybeats (CYBCF)?

The current stock price of Cybeats (CYBCF) is $0.085 as of March 3, 2025.

What is the market cap of Cybeats (CYBCF)?

The market cap of Cybeats (CYBCF) is approximately 10.6M.

What is Cybeats Technologies Corp. known for?

Cybeats specializes in cybersecurity solutions, focusing on Software Bill of Materials (SBOM) management and software supply chain intelligence.

What industries does Cybeats serve?

Cybeats serves diverse industries, including healthcare, industrial automation, and government sectors, addressing their unique cybersecurity needs.

How does Cybeats' SBOM Studio help organizations?

SBOM Studio streamlines software vulnerability management, ensures regulatory compliance, and enhances supply chain transparency for its clients.

What is the significance of SBOM Consumer?

SBOM Consumer is tailored for organizations that procure software, simplifying SBOM ingestion, validation, and continuous monitoring to enhance security.

How does Cybeats align with global regulations?

Cybeats' solutions comply with regulations like the U.S. Executive Order 14028 and the EU Cyber Resilience Act, ensuring clients meet stringent cybersecurity standards.